Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Z Duan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|March 26, 2009
Two commonly used methods for exposure-adverse events analysis: comparisons and evaluationsJohn Z Duan
Drugs in R&D|June 1, 2010
Drug-drug interaction pattern recognitionJohn Z Duan
Journal of Pharmaceutical Sciences|August 18, 2020
A Biopharmetrics Approach for Drug Product Quality Control with Clinical RelevanceJohn Z Duan
The AAPS Journal|March 7, 2019
Dissolution Edge Charts for Immediate Release Products and Their Applications: a Simulation Study to Aid the Setting of SpecificationsJohn Z Duan
Journal of Pharmaceutical Sciences|December 17, 2013
Influence of drug property and product design on in vitro-in vivo correlation of complex modified-release dosage formsYihong Qiu, Xia Li, John Z Duan
Pharmaceutical Research|February 3, 2011
In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match?John Z Duan, Kareen Riviere, Patrick Marroum
Journal of Clinical Pharmacology|September 25, 2010
Bioavailability considerations in evaluating drug-drug interactions using the population pharmacokinetic approachJohn Z Duan, Andre J Jackson, Ping Zhao
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|March 26, 2009
Two commonly used methods for exposure-adverse events analysis: comparisons and evaluationsJohn Z Duan
Drugs in R&D|June 1, 2010
Drug-drug interaction pattern recognitionJohn Z Duan
Journal of Pharmaceutical Sciences|August 18, 2020
A Biopharmetrics Approach for Drug Product Quality Control with Clinical RelevanceJohn Z Duan
The AAPS Journal|March 7, 2019
Dissolution Edge Charts for Immediate Release Products and Their Applications: a Simulation Study to Aid the Setting of SpecificationsJohn Z Duan
Journal of Pharmaceutical Sciences|December 17, 2013
Influence of drug property and product design on in vitro-in vivo correlation of complex modified-release dosage formsYihong Qiu, Xia Li, John Z Duan
Pharmaceutical Research|February 3, 2011
In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match?John Z Duan, Kareen Riviere, Patrick Marroum
Journal of Clinical Pharmacology|September 25, 2010
Bioavailability considerations in evaluating drug-drug interactions using the population pharmacokinetic approachJohn Z Duan, Andre J Jackson, Ping Zhao
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Pageof 1